Abstract:Abstract The development of efficient aggregation‐induced emission (AIE) active probes is crucial for disease diagnosis, particularly for tumors and cardiovascular diseases. Current AIE‐active probes primarily focus on improving their water solubility to resist aggregation, thereby achieving an initial fluorescence‐off state. However, the complex biological environment can cause undesirable aggregation, resulting in false signals. To address this issue, we have ingeniously introduced an azo group into the AIE luminogen (AIEgen), developing a reductase‐activated AIE probe, Azo‐quinoline‐malononitrile (QM)‐PN, for imaging hypoxic environments. In this probe, the azo group promotes intramolecular motion through rapid E / Z isomerization, causing the excited state energy to dissipate via non‐radiative decay, thus turning off the initial fluorescence. In the presence of reductase, Azo‐QM‐PN is reduced and cleaved to produce the hydrophobic AIEgen NH 2 ‐QM‐PN, which subsequently aggregates and generates an in situ AIE signal, thereby imaging the hypoxic environment with reductase. Encapsulation of Azo‐QM‐PN with DSPE‐PEG 2000 results in the formation of the nanoprobe Azo‐QM‐PN NPs, which can effectively penetrate cell membranes, specifically illuminate tumor cells, monitor fluctuations in azo reductase levels, and deeply penetrate and image multicellular tumor spheroids, demonstrating potential for hypoxic tumor imaging. Additionally, the nanoprobe Azo‐QM‐PN NPs can selectively image hypoxic atherosclerotic plaque tissues, showing potential for detecting atherosclerosis. Therefore, in this study, we successfully developed an enzyme‐activated AIE probe for imaging hypoxic environments, laying the foundation for further clinical applications.

Activatable Fluorescent Probe Based on Aggregation-Induced Emission for Detecting Hypoxia-Related Pathological Conditions.

Ultrasensitive near-infrared fluorescence probe activated by nitroreductase for in vivo hypoxia detection

Hypoxia Imaging in Cells and Tumor Tissues Using a Highly Selective Fluorescent Nitroreductase Probe.

Near-Infrared Fluorescent Probes for Hypoxia Detection via Joint Regulated Enzymes: Design, Synthesis, and Application in Living Cells and Mice.

An azo substituted quinoline‐malononitrile enzyme‐activable aggregation‐induced emission nanoprobe for hypoxia imaging

An activatable azophenyl fluorescent probe for hypoxic fluorescence imaging in living cells

A Novel Off-on Fluorescent Probe for Imaging of Hypoxia in Tumor Cell

A New Aggregation-Induced Emission Fluorescent Probe for Rapid Detection of Nitroreductase and Its Application in Living Cells.

A Probe for the Detection of Hypoxic Cancer Cells.

Efficient Two-Photon Fluorescent Probe for Nitroreductase Detection and Hypoxia Imaging in Tumor Cells and Tissues

Hypoxia-triggered single molecule probe for high-contrast NIR II/PA tumor imaging and robust photothermal therapy

Fluorescent Probe for Hypoxia-triggered Imaging and Cancer Therapy

A novel near-infrared fluorescence off-on probe for imaging hypoxia and nitroreductase in cells and in vivo

Hypoxia-Responsive Molecular Probe Lighted up by Peptide Self-Assembly for Cancer Cell Imaging

Mitochondrial-targeting Fluorescent Probe Awakened by Nitroreductase for Hypoxic Imaging and Surgical Navigation of Solid Tumors

Progress in fluorescent probes for tumor hypoxia

A cresyl violet-based fluorescent off-on probe for the detection and imaging of hypoxia and nitroreductase in living organisms.

A Highly Sensitive Long-Wavelength Fluorescence Probe for Nitroreductase and Hypoxia: Selective Detection and Quantification.

A highly sensitive NIR fluorescence probe for hypoxia imaging in cells and ulcerative colitis

A Nitroreductase Responsive and Photoactivated Fluorescent Probe for Dual-Controlled Tumor Hypoxia Imaging

A Highly Sensitive Chemiluminescent Probe for Detecting Nitroreductase and Imaging in Living Animals.